SCHEMBL3681789

SCHEMBL3681789

CC(C)n1cnc2c(NCc3cccnc3)nc(NCCCC(C)(C)O)nc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 20/20 0.71
CDK9 P50750 7/20 0.71
CDK1 P06493 15/20 0.70
CCNE1 P24864 14/20 0.70
CDK4 P11802 13/20 0.70
CDK7 P50613 13/20 0.70
MAPK1 P28482 12/20 0.70
CCNH P51946 12/20 0.70
CCNB1 P14635 12/20 0.70
CCND1 P24385 11/20 0.70
CCNT1 O60563 4/20 0.70
CDK5 Q00535 3/20 0.65
MNAT1 P51948 1/20 0.65
CDK6 Q00534 1/20 0.65
CCNB2 O95067 1/20 0.64
CCNB3 Q8WWL7 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
CDK5R1 Q15078 1/20 0.62
CSNK1D P48730 1/20 0.61
CLK2 P49760 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5072601 0.88 CDK2 (0.81) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL3681786 0.85 CDK2 (0.72) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL3300735 0.83 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL3300752 0.83 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL3305160 0.83 CDK2 (0.75) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL1376524 0.82 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL1374946 0.82 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL1379209 0.82 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL3300432 0.81 CDK2 (1.00) CDK2CDK9CDK1CCNE1CDK4
SCHEMBL14396823 0.81 CDK2 (0.81) CDK2CDK9CDK1CCNE1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139486-A1 COMBINATION OF A PURINE-BASED CDK INHIBITOR WITH A TYROSINE KINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2010-01-06 EP disclosed
WO-2008122779-A1 COMBINATION OF A PURINE-BASED CDK INHIBITOR WITH A TYROSINE KINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2008-10-16 WO disclosed